Table 3. Patient's Characteristics Between Non-Relapse and Relapse Group.
| Variable | non-Relapse n=67 |
Relapse n=21 |
P-value |
|---|---|---|---|
| Gender (M/F) | 34/23 | 11/10 | 0.564 |
| Age at diagnosis (yr), median (range) | 33 (10–75) | 35 (15–71) | 0.169 |
| Extent of disease | 0.265 | ||
| Extensive colitis | 21 (31.3) | 11 (52.4) | |
| Left-sided | 15 (22.4) | 6 (28.6) | |
| Proctitis | 30 (44.8) | 4 (19.0) | |
| Unclear | 1 (1.5) | 0 (0) | |
| Endoscopic Mayo score | 0.167 | ||
| Mayo-0 | 36 (53.7) | 7 (33.3) | |
| Mayo-1 | 31 (46.3) | 14 (66.7) | |
| Maintenance therapy | |||
| 5-ASA | 53 (79.1) | 19 (90.5) | 0.338 |
| AZA/6MP | 6 (9.0) | 6 (28.6) | 0.055 |
| GMAA | 1 (1.5) | 0 (0) | 1.000 |
| TNF-α antagonist | 3 (4.5) | 3 (14.3) | 0.145 |
| None | 6 (9.0) | 2 (9.5) | 1.000 |
| History of treatment with corticosteroid | 17 (25.4) | 6 (28.6) | 0.995 |
| Corticosteroid refractory | 3 (4.5) | 1 (4.8) | 1.000 |
| Corticosteroid dependent | 4 (6.0) | 2 (9.5) | 0.626 |
Values are presented as n (%).
Categorical and continuous data were compared using a two-tailed Fisher exact test, Chi-squared test and Mann-Whitney U test.
M, male; F, female; 5-ASA, 5-aminosalicylic acid; AZA/6MP, Azathioprine/6-mercaptopurine; GMAA, granulocyte monocyte adsorption apheresis; TNF, tumor necrosis factor.